New Concept 2000 Sprl has been acquired by a private nursing home group
New Concept 2000 Sprl has been successfully sold to a private nursing home group as a consequence of the ongoing consolidation in the Belgian nursing home market. The main driver for this consolidation is stricter regulation and the accompanying need for capital expenditure.
Founded in 1998, New Concept 2000 Sprl owns three nursing homes—La Fontaine, La Colombière and La Roseraie—operating one of them, La Fontaine. In 2008, Wallogistic Sprl was created as a food catering and laundry services provider as well as a central purchasing unit, mainly for hygienic products. Its clients are almost exclusively these three nursing homes, but its scope of activity can be extended to third parties. In 2009, Gesvesenior Asbl was established and is responsible for operating La Colombière and La Roseraie. In total, the company operates more than 160 beds.
The acquirors are private investors who operate a nursing home group with approximately five entities in the Walloon region of Belgium.
The company Wallogistic was not included in the scope of the sale and therefore remains under the sellers’ ownership.
Oaklins’ team in Belgium acted as the exclusive M&A sell-side advisor to New Concept 2000 in this transaction.
Talk to the deal team
Amelie Arrazola de Onate
Oaklins KBC Securities
Related deals
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn moreEuroHospital Varna has been acquired by Intermedica Group
EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.
Learn moreOlyos Group has acquired a controlling stake in NewScience
Olyos Group has acquired a controlling stake in NewScience from its founders through a transaction structured in two stages, with the strategic objective of ultimately acquiring 100% of the company. The transaction forms part of NewScience’s international growth strategy and a gradual cash-out process for the founder, who intends to complete a full exit. Olyos intends to retain the management team through a put and call option mechanism and an earn-out linked to NewScience’s 2025 EBITDA.
Learn more